Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
In a post on X, Hims & Hers' chief executive, Andrew Dudum, said that the company will "continue to offer access to personalised treatments as allowed by law to meet patient needs," and will be "closely monitoring" the semaglutide supply chain, given that Novo Nordisk "stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications'." For its part, the FDA said it "has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved." The agency will continue to allow compounders to provide semaglutide to patients on a temporary basis "to avoid unnecessary disruption to patient treatment." State-licensed pharmacy or physician compounders can continue to do so until 22nd April, while outsourcing facilities have a deadline of 22nd May
Coverage is increasingly decided at the employer level, with some offering optional riders for an additional premium
Abdominal pain, discomfort, or bloating may occur in approximately ten percent of patients receiving Semaglutide / Cyanocobalamin Injection
Semaglutide is a readily accessible peptide and compounding pharmacies can easily make this medication for providers, but some providers elect to make their semaglutide cost more as it is in such high demand
US$ 20.59
US$ 24.73
US$ 20.82
US$ 22.69
US$ 29.35
